PEOPLE - Cytyc Corporation (US) makes appointment:
This article was originally published in Clinica
Cytyc Corporation (Boxborough, Massachusetts), a developer of diagnostic products primarily focused on women's health, such as breast and cervical cancer risk assessment, has named Euphemia McGoogan as medical director of Europe. Dr McGoogan will act in an advisory capacity in areas such as clinical trials evaluation and new product opportunities across Europe.
You may also be interested in...
AMAG outlines plans for retrospective real-world evidence studies, and possibly a new placebo-controlled trial with a primary endpoint of preterm birth <32 weeks, in a filing opposing the Center for Drug Evaluation and Research’s proposal to withdraw the drug.
The leading Korean pharma firm’s oral, third-generation EGFR-TKI is approved in the country, providing a new option for patients with advanced NSCLC and increasing hopes for global approvals given an ongoing global Phase III combination trial led by partner J&J.
DePuy Synthes expects its Velys robotic-assisted system to be cost-effective, easy-to-use and to be well-suited for use in ambulatory surgery centers.